The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACCELERON PHARMA INC | COM | 00434H108 | 3,039 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 5,072 | 290,000 | SH | SOLE | 290,000 | 0 | 0 | ||
AGIOS PHARMACEUTICALS | COM | 00847X104 | 6,688 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ARATANA THERAPEUTICS INC | COM | 03874P101 | 2,279 | 350,200 | SH | SOLE | 350,200 | 0 | 0 | ||
ARDELYX | COM | 039697107 | 2,787 | 546,500 | SH | SOLE | 546,500 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 1,203 | 970,000 | SH | SOLE | 970,000 | 0 | 0 | ||
AUDENTES THERAPEUTICS INC | COM | 05070R104 | 2,869 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
AXOGEN INC | COM | 05463X106 | 32,997 | 1,970,000 | SH | SOLE | 1,970,000 | 0 | 0 | ||
BIOLINERX LTD | SPONSORED ADR | 09071M106 | 212 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
BLUEPRINT MEDICINES | COM | 09627Y109 | 44,589 | 880,000 | SH | SOLE | 880,000 | 0 | 0 | ||
CHIMERIX INC | COM | 16934W106 | 6,976 | 1,280,000 | SH | SOLE | 1,280,000 | 0 | 0 | ||
CODEXIS INC | COM | 192005106 | 8,011 | 1,470,000 | SH | SOLE | 1,470,000 | 0 | 0 | ||
CORIUM INTERNATIONAL INC | COM | 21887L107 | 5,334 | 715,000 | SH | SOLE | 715,000 | 0 | 0 | ||
CYTOMX THERAPEUTICS INC | COM | 23284F105 | 7,130 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
EAGLE PHARMACEUTICALS INC | COM | 269796108 | 4,733 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
EDGE THERAPEUTICS INC | COM | 279870109 | 1,334 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
ENANTA PHARMACEUTICALS INC | COM | 29251M106 | 3,598 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
FIBROGEN INC | COM | 31572Q808 | 11,628 | 360,000 | SH | SOLE | 360,000 | 0 | 0 | ||
FOAMIX PHARMACEUTICALS LTD | SHS | M46135105 | 5,266 | 1,135,000 | SH | SOLE | 1,135,000 | 0 | 0 | ||
GLOBAL BLOOD THERAPEUTICS IN | COM | 37890U108 | 1,094 | 40,000 | SH | SOLE | 40,000 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 7,947 | 900,000 | SH | SOLE | 900,000 | 0 | 0 | ||
IMPRIMIS PHARMACEUTICALS INC | COM NEW | 45323A201 | 2,864 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 04611X101 | 1,056 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
LOXO ONCOLOGY | COM | 548862101 | 10,425 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
MIRNA THERAPEUTICS INC | COM | 60470J103 | 1,917 | 1,148,100 | SH | SOLE | 1,148,100 | 0 | 0 | ||
MOMENTA PHARMACEUTICALS INC | COM | 60877T100 | 7,605 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
NEOS THERAPEUTICS INC | COM | 64052L106 | 365 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
NEURODERM LTD | ORD SHS | M74231107 | 3,597 | 120,300 | SH | SOLE | 120,300 | 0 | 0 | ||
NOVELION THERAPEUTICS INC | COM NEW | 67001K202 | 6,922 | 750,000 | SH | SOLE | 750,000 | 0 | 0 | ||
PROTALIX BIOTHERAPEUTICS INC | COM | 74365AAB7 | 1,537 | 1,835,000 | SH | SOLE | 1,835,000 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 4,600 | 85,000 | SH | SOLE | 85,000 | 0 | 0 | ||
SANGAMO BIOSCIENCES INC | COM | 800677106 | 5,104 | 580,000 | SH | SOLE | 580,000 | 0 | 0 | ||
STRONGBRIDGE BIOPHARMA PLC | COM | G85347105 | 8,437 | 1,180,000 | SH | SOLE | 1,180,000 | 0 | 0 | ||
SUNESIS PHARMACEUTICALS INC | COM PAR | 867328700 | 1,026 | 380,000 | SH | SOLE | 380,000 | 0 | 0 | ||
SYROS PHARMACEUTICALS INC | COM | 87184Q107 | 1,762 | 109,500 | SH | SOLE | 109,500 | 0 | 0 | ||
TETRAPHASE PHARMACEUTICALS I | COM | 88165N105 | 2,353 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
THERAVANCE BIOPHARMA INC | COM | G8807B106 | 7,171 | 180,000 | SH | SOLE | 180,000 | 0 | 0 | ||
TONIX PHARMACEUTICALS HOLDING | COM NEW | 890260201 | 1,602 | 370,000 | SH | SOLE | 370,000 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | 2,325 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
XOMA CORP DEL | COM NEW | 98419J206 | 2,217 | 317,200 | SH | SOLE | 317,200 | 0 | 0 | ||
ZOSANO PHARMA CORP | COM | 98979H103 | 1,727 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 |